Synonyms- |
Introduction- |
Mechanism HLA class I antigen modulators [+2] |
Active Org. |
Originator Org. ![]() |
Active Indication |
Inactive Indication- |
Drug Highest PhaseNDA/BLA |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism HLA class II antigen modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Mechanism HLA class II antigen modulators [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Feb 2024 |
Sponsor / Collaborator |
Start Date16 Mar 2022 |
Sponsor / Collaborator ![]() [+2] |
Start Date15 Feb 2022 |
Sponsor / Collaborator |